当前位置:首页 - 行情中心 - 广康生化(300804) - 财务分析 - 现金流量表

广康生化

(300804)

  

流通市值:10.26亿  总市值:27.61亿
流通股本:2750.00万   总股本:7400.00万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金91,069,802.74557,486,219.82409,296,882.92271,338,320.55
  收到的税费返还9,787,532.3828,744,613.1221,225,086.6916,909,280.25
  收到其他与经营活动有关的现金1,575,835.375,016,552.582,567,108.51880,302.93
  经营活动现金流入小计102,433,170.49591,247,385.52433,089,078.12289,127,903.73
  购买商品、接受劳务支付的现金111,785,590.69340,343,688.08263,239,333.7171,269,694.32
  支付给职工以及为职工支付的现金30,916,634.45104,058,954.4980,333,476.7253,832,213.55
  支付的各项税费374,606.298,788,933.86,947,864.972,808,984.62
  支付其他与经营活动有关的现金17,342,200.6457,136,480.6441,283,247.5522,543,672.21
  经营活动现金流出小计160,419,032.07510,328,057.01391,803,922.94250,454,564.7
  经营活动产生的现金流量净额-57,985,861.5880,919,328.5141,285,155.1838,673,339.03
二、投资活动产生的现金流量:
  收回投资收到的现金150,000,0002,202,000,0002,172,000,0001,757,000,000
  取得投资收益收到的现金511,717.775,858,700.645,787,239.234,005,471.5
  投资活动现金流入小计150,511,717.772,207,858,700.642,177,787,239.231,761,005,471.5
  购建固定资产、无形资产和其他长期资产支付的现金126,194,415.07231,548,308.38159,434,628.3480,687,138.45
  投资支付的现金39,000,0002,122,000,0001,872,000,0001,717,000,000
  投资活动现金流出小计165,194,415.072,353,548,308.382,031,434,628.341,797,687,138.45
  投资活动产生的现金流量净额-14,682,697.3-145,689,607.74146,352,610.89-36,681,666.95
三、筹资活动产生的现金流量:
  吸收投资收到的现金---0
  取得借款收到的现金110,496,876.08338,068,640.28297,438,945.18190,156,764.01
  收到其他与筹资活动有关的现金13,983,535.4243,107,081.4629,862,433.5917,354,930.45
  筹资活动现金流入小计124,480,411.5381,175,721.74327,301,378.77207,511,694.46
  偿还债务支付的现金94,519,882.21199,054,403.18137,713,921.595,392,621.47
  分配股利、利润或偿付利息支付的现金2,848,987.9510,978,161.847,998,290.45,509,877.95
  支付其他与筹资活动有关的现金3,886,920.2855,941,142.3341,713,710.9126,051,669.05
  筹资活动现金流出小计101,255,790.44265,973,707.35187,425,922.81126,954,168.47
  筹资活动产生的现金流量净额23,224,621.06115,202,014.39139,875,455.9680,557,525.99
四、汇率变动对现金及现金等价物的影响-916,708.91,312,615.261,389,431.871,208,425.61
五、现金及现金等价物净增加额-50,360,646.7251,744,350.42328,902,653.983,757,623.68
  加:期初现金及现金等价物余额173,460,018.23121,715,667.81122,488,135.19122,488,135.19
  期末现金及现金等价物余额123,099,371.51173,460,018.23451,390,789.09206,245,758.87
补充资料:
  净利润-40,417,901.23-29,069,021.73
  资产减值准备-2,283,946.97-461,953.88
  固定资产和投资性房地产折旧-65,735,771.25-32,142,116.03
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-65,735,771.25-32,142,116.03
  无形资产摊销-3,780,115.34-1,220,302.13
  长期待摊费用摊销-2,310,958.92-1,084,284.86
  处置固定资产、无形资产和其他长期资产的损失-15,128.49-15,128.49
  固定资产报废损失-3,212,438.76-2,606,331.19
  公允价值变动损失--289,556.61--
  财务费用-10,533,618.9-4,269,758.56
  投资损失--6,368,040.75--3,881,934.58
  递延所得税--1,040,455.76-429,042.29
  其中:递延所得税资产减少--458,293.81-771,600.36
    递延所得税负债增加--582,161.95--342,558.07
  存货的减少--71,834,618.15--42,977,853.24
  经营性应收项目的减少--125,850,871.74-12,057,673.48
  经营性应付项目的增加-156,970,361.99--958,104.6
  其他---2,580,858.39
  现金的期末余额-173,460,018.23-206,245,758.87
  减:现金的期初余额-121,715,667.81-122,488,135.19
  现金及现金等价物的净增加额-51,744,350.42-83,757,623.68
公告日期2026-04-242026-04-242025-10-242025-08-22
审计意见(境内)标准无保留意见
TOP↑